Oncotarget

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 01/12/2018.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Research Papers:

Nuclear receptor REV-ERBα attenuates lipopolysaccharide-induced acute lung injury and inflammation through TLR4 inhibition

Dapeng Yu _, Dapeng Yu, Yong Li, Yong Li, Yu Zhou, Yu Zhou, Masanobu Abe, Masanobu Abe, Liang Zong, Liang Zong, Ju Gao and Ju Gao _

 

Dapeng Yu1,2,*, Yong Li2,*, Yu Zhou3,4,*, Masanobu Abe5, Liang Zong4,6 and Ju Gao1,2

1 Graduate School of Medicine, The Second Xiangya Hospital of Central South University, Changsha, China

2 Department of Anesthesiology, Clinical Medical School of Yangzhou University (Subei People’s Hospital of Jiangsu Province), Yangzhou, Jiangsu, China

3 Department of General Surgery, Suzhou Municipal Hospital (North Campus), Suzhou, Jiangsu, China

4 Department of Gastrointestinal Surgery, Clinical Medical College of Yangzhou University(the Northern Jiangsu People’s Hospital), Yangzhou, Jiangsu, China

5 Division for Health Service Promotion, University of Tokyo, Tokyo, Japan

6 Department of Gastrointestinal Surgery, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan

* These authors contributed equally to this work

Correspondence to:

Liang Zong, email: [email protected]

Ju Gao, email: [email protected]

Keywords: : rev-erbα; lipopolysaccharide; acute lung injury; nuclear factor-kappa B; toll-like receptor 4

Received: April 04, 2017    Accepted: December 05, 2017    Epub: January 12, 2018


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24207